AstraZeneca is in phase three trial with its vaccine and looks to file for emergency use with the FDA next month.
Daily Covid-19 Minute: Astrazeneca Vaccine
CBS 62 Detroit
Drugmaker AstraZeneca announced some promising results from their phase 3 covid vaccine trial reporting their vaccine was 79%..
